EVGN Annual CFI
-$4.54 M
-$17.81 M-134.19%
31 December 2023
Summary:
As of January 23, 2025, EVGN annual cash flow from investing activities is -$4.54 million, with the most recent change of -$17.81 million (-134.19%) on December 31, 2023. During the last 3 years, it has fallen by -$13.95 million (-148.20%). EVGN annual CFI is now -112.22% below its all-time high of $37.14 million, reached on December 31, 2019.EVGN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN Quarterly CFI
$2.02 M
-$1.19 M-37.20%
01 September 2024
Summary:
As of January 23, 2025, EVGN quarterly cash flow from investing activities is $2.02 million, with the most recent change of -$1.19 million (-37.20%) on September 1, 2024. Over the past year, it has dropped by -$1.63 million (-44.68%). EVGN quarterly CFI is now -91.29% below its all-time high of $23.14 million, reached on December 31, 2019.EVGN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN TTM CFI
$278.00 K
-$1.63 M-85.41%
01 September 2024
Summary:
As of January 23, 2025, EVGN TTM cash flow from investing activities is $278.00 thousand, with the most recent change of -$1.63 million (-85.41%) on September 1, 2024. Over the past year, it has increased by +$4.68 million (+106.32%). EVGN TTM CFI is now -99.25% below its all-time high of $37.14 million, reached on December 31, 2019.EVGN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVGN Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -134.2% | -44.7% | +106.3% |
| 3 y3 years | -148.2% | +551.0% | -97.9% |
| 5 y5 years | -126.2% | +41.1% | -98.8% |
EVGN Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -134.2% | +77.9% | -83.2% | +125.5% | -98.7% | +101.3% |
| 5 y | 5-year | -112.2% | +77.9% | -91.3% | +106.8% | -99.3% | +101.2% |
| alltime | all time | -112.2% | +94.6% | -91.3% | +102.6% | -99.3% | +100.3% |
Evogene Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.02 M(-37.2%) | $278.00 K(-85.4%) |
| June 2024 | - | $3.21 M(-173.6%) | $1.91 M(-120.7%) |
| Mar 2024 | - | -$4.36 M(+644.4%) | -$9.20 M(+102.8%) |
| Dec 2023 | -$4.54 M(-134.2%) | -$586.00 K(-116.1%) | -$4.54 M(+3.2%) |
| Sept 2023 | - | $3.64 M(-146.1%) | -$4.40 M(-45.5%) |
| June 2023 | - | -$7.90 M(-2698.7%) | -$8.06 M(-605.3%) |
| Mar 2023 | - | $304.00 K(-168.0%) | $1.60 M(-88.0%) |
| Dec 2022 | $13.27 M(-164.5%) | -$447.00 K(+1931.8%) | $13.27 M(-15.6%) |
| Sept 2022 | - | -$22.00 K(-101.2%) | $15.73 M(+11.0%) |
| June 2022 | - | $1.76 M(-85.3%) | $14.17 M(-33.1%) |
| Mar 2022 | - | $11.98 M(+496.7%) | $21.18 M(-203.0%) |
| Dec 2021 | -$20.57 M(-318.4%) | $2.01 M(-226.8%) | -$20.57 M(-9.3%) |
| Sept 2021 | - | -$1.58 M(-118.0%) | -$22.68 M(+39.5%) |
| June 2021 | - | $8.77 M(-129.5%) | -$16.26 M(-31.1%) |
| Mar 2021 | - | -$29.76 M(>+9900.0%) | -$23.60 M(-350.7%) |
| Dec 2020 | $9.41 M(-74.6%) | -$103.00 K(-102.1%) | $9.41 M(-71.2%) |
| Sept 2020 | - | $4.84 M(+238.4%) | $32.66 M(+38.0%) |
| June 2020 | - | $1.43 M(-56.1%) | $23.66 M(-30.9%) |
| Mar 2020 | - | $3.25 M(-85.9%) | $34.25 M(-7.8%) |
| Dec 2019 | $37.14 M(+114.0%) | $23.14 M(-656.0%) | $37.14 M(+122.5%) |
| Sept 2019 | - | -$4.16 M(-134.6%) | $16.69 M(+5.4%) |
| June 2019 | - | $12.01 M(+95.5%) | $15.84 M(-4.8%) |
| Mar 2019 | - | $6.15 M(+128.0%) | $16.65 M(-4.1%) |
| Dec 2018 | $17.35 M | $2.70 M(-153.8%) | $17.35 M(-9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | -$5.01 M(-139.1%) | $19.12 M(-21.3%) |
| June 2018 | - | $12.82 M(+87.1%) | $24.29 M(+38.1%) |
| Mar 2018 | - | $6.85 M(+53.5%) | $17.59 M(+15.4%) |
| Dec 2017 | $15.24 M(+278.5%) | $4.46 M(+2706.9%) | $15.24 M(+23.3%) |
| Sept 2017 | - | $159.00 K(-97.4%) | $12.36 M(-18.7%) |
| June 2017 | - | $6.12 M(+35.9%) | $15.21 M(+19.7%) |
| Mar 2017 | - | $4.50 M(+185.4%) | $12.71 M(+215.5%) |
| Dec 2016 | $4.03 M(-76.8%) | $1.58 M(-47.5%) | $4.03 M(-23.0%) |
| Sept 2016 | - | $3.01 M(-16.9%) | $5.23 M(-41.3%) |
| June 2016 | - | $3.62 M(-186.6%) | $8.91 M(+60.7%) |
| Mar 2016 | - | -$4.18 M(-250.2%) | $5.54 M(-68.1%) |
| Dec 2015 | $17.39 M(-120.7%) | $2.78 M(-58.4%) | $17.39 M(+186.9%) |
| Sept 2015 | - | $6.69 M(+2533.1%) | $6.06 M(-0.3%) |
| June 2015 | - | $254.00 K(-96.7%) | $6.08 M(+320.2%) |
| Mar 2015 | - | $7.66 M(-189.7%) | $1.45 M(-101.7%) |
| Dec 2014 | -$84.03 M(+2797.6%) | -$8.55 M(-227.5%) | -$84.03 M(+11.2%) |
| Sept 2014 | - | $6.70 M(-253.2%) | -$75.58 M(-6.5%) |
| June 2014 | - | -$4.38 M(-94.4%) | -$80.82 M(+3.1%) |
| Mar 2014 | - | -$77.81 M(>+9900.0%) | -$78.36 M(+2602.1%) |
| Dec 2013 | -$2.90 M(-115.7%) | -$100.00 K(-106.8%) | -$2.90 M(+3.6%) |
| Sept 2013 | - | $1.47 M(-176.6%) | -$2.80 M(-34.4%) |
| June 2013 | - | -$1.92 M(-18.3%) | -$4.27 M(+81.7%) |
| Mar 2013 | - | -$2.35 M | -$2.35 M |
| Dec 2012 | $18.48 M(-160.4%) | - | - |
| Dec 2011 | -$30.58 M | - | - |
FAQ
- What is Evogene annual cash flow from investing activities?
- What is the all time high annual CFI for Evogene?
- What is Evogene annual CFI year-on-year change?
- What is Evogene quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Evogene?
- What is Evogene quarterly CFI year-on-year change?
- What is Evogene TTM cash flow from investing activities?
- What is the all time high TTM CFI for Evogene?
- What is Evogene TTM CFI year-on-year change?
What is Evogene annual cash flow from investing activities?
The current annual CFI of EVGN is -$4.54 M
What is the all time high annual CFI for Evogene?
Evogene all-time high annual cash flow from investing activities is $37.14 M
What is Evogene annual CFI year-on-year change?
Over the past year, EVGN annual cash flow from investing activities has changed by -$17.81 M (-134.19%)
What is Evogene quarterly cash flow from investing activities?
The current quarterly CFI of EVGN is $2.02 M
What is the all time high quarterly CFI for Evogene?
Evogene all-time high quarterly cash flow from investing activities is $23.14 M
What is Evogene quarterly CFI year-on-year change?
Over the past year, EVGN quarterly cash flow from investing activities has changed by -$1.63 M (-44.68%)
What is Evogene TTM cash flow from investing activities?
The current TTM CFI of EVGN is $278.00 K
What is the all time high TTM CFI for Evogene?
Evogene all-time high TTM cash flow from investing activities is $37.14 M
What is Evogene TTM CFI year-on-year change?
Over the past year, EVGN TTM cash flow from investing activities has changed by +$4.68 M (+106.32%)